Feb. 14, 2005 — The European Commission has approved a potent hepatitis B adjuvant vaccine for use in specific high-risk groups; Japan's Ministry of Health, Labor, and Welfare has approved ...
CHICAGO, IL — Cryoballoon ablation efficacy and safety was on par with radiofrequency catheter (RFC) ablation for the treatment of paroxysmal atrial fibrillation (PAF), results of the FIRE and ICE ...
Please provide your email address to receive an email when new articles are posted on . Four different pulmonary vein isolation techniques demonstrated similar efficacy in treating persistent AF.
Boston Scientific is giving new meaning to the polar plunge. The medtech giant has received FDA approval for a catheter that uses extreme cold to attack the irregular mechanisms of the pulmonary vein ...
Devices already in inventory can be used with the updated instructions by doctors. Patients already treated don’t need to do anything. Boston Scientific has updated its instructions for doctors using ...
Please provide your email address to receive an email when new articles are posted on . A novel catheter for very high-power short-duration ablation for pulmonary vein isolation reduced procedure time ...
The primary effectiveness outcomes are shown for both the full patient cohort (A) and separated by atrial fibrillation (AF) subtype: paroxysmal AF (B) vs persistent AF/long-standing (LS)–persistent AF ...
WATERTOWN, MA – Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today first-in-human use of its circumferential Pulmonary Vein ...
Catheter-based pulmonary-vein isolation with thermal ablation is effective for atrial fibrillation. How pulsed field ablation, a nonthermal method, compares with cryoablation when atrial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback